Maruti Suzuki shares rose after a strong Q4 performance, with analysts positive on domestic demand outlook despite near-term pressure on margins from higher costs.
Cipla has received the US FDA's approval for generic Ventolin inhaler. Analysts see $100-million sales potential from the drug, which could aid US business outlook
IKS Health shares surged 9.5 per cent after announcing a $557-million TruBridge acquisition. The deal, it said, will boost EPS outlook, add EHR SaaS, and unlock $575-million cross-sell potential
Techno Electric & Engineering Company is a leading EPC player in India's power transmission and distribution sector with over 45 years of experience and a proven track record across major projects
Jubilant is going through a strategic transformation from a commodity-heavy business to a specialised niche player, aiming to increase the share of speciality products across segments
Motilal Oswal sees 30% upside in Dixon Technologies share price despite near-term headwinds from weak smartphone demand and rising costs. The brokerage has reiterated 'Buy' with ₹14,700 target price
Jefferies has downgraded Indus Towers shares to 'Underperform', cutting target price to ₹375. The global brokerage stated renewal risks, rising capex, and pressure on earnings and valuations as risks
DMart is unlikely to see meaningful same-store sales growth improvement, except for seasonal fluctuations and possible price hikes by brands, given the competitive intensity in the sector
Aurionpro Solutions has delivered around 33 per cent CAGR in revenue over FY21-25, supported by improved operational efficiency and sustained product development